Interaction between interferon γ and insulin‐like growth factor‐1 in hippocampus impacts on the ability of rats to sustain long‐term potentiation
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
There is compelling evidence to suggest that inflammation significantly contributes to neurodegenerative changes. Consistent with this is the observation that several neurodegenerative disorders are accompanied by an increase in the concentration of interleukin (IL)‐1β. IL‐1β has a negative impact on synaptic plasticity and therefore an increased concentration of IL‐1β, such as that in the hippocampus of the aged rat, is associated with a deficit in long‐term potentiation (LTP). IL‐1β is derived mainly from activated microglia but the trigger leading to this activation, specifically in the aged brain, remains to be identified. Here we examined the possiblity that interferon (IFN)γ may stimulate microglial activation and increase IL‐1β concentration, thereby inhibiting LTP. The IFNγ concentration was increased in hippocampus prepared from aged, compared with young, rats and inversely correlated with the ability of rats to sustain LTP. Intracerebroventricular injection of IFNγ inhibited LTP, and increased microglial activation was observed in both IFNγ‐injected and aged rats. The age‐related increase in IFNγ was accompanied by a decrease in the hippocampal concentration of insulin‐like growth factor (IGF)‐1. The evidence presented suggests that IGF‐1 acts to antagonize the IFNγ‐induced microglial activation, the accompanying increase in IL‐1β concentration and the consequent deficit in LTP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Li, Y., Liu, L., Barger, S. W., & Griffin, W. S. T. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01605.2003 · Cited by 563
Wang, Q., Walsh, D. M., Rowan, M. J., Selkoe, D. J., & Anwyl, R. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1633-03.2004 · Cited by 437
Murray, C. A., & Lynch, M. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02974.1998 · Cited by 359
Self-citationZheng, W., & Quirion, R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02350.x · Cited by 225 · cited 1×
“…which play a role in expression of LTP (Kelly and Lynch 2000), and which are triggered by interaction of IGF-1 with its receptor (Wang et al. 1995; Zheng and Quirion 2004), are decreased with age, with a more profound and significant change in hippocampal tissue prepared from aged rats that…”
BackgroundBernardo, A., Levi, G., & Minghetti, L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00110.x · Cited by 222 · cited 2×
“Intracerebroventricular injection of IFNc increased microglial activation and this is a significant observation as previous studies indicating that IFNc induced such a change focused largely on analysis of changes in cultured glial preparations (Bernardo et al. 2000; Kim et al. 2004; Townsend et al. 2004).”
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice
Tan, J., Town, T., Crawford, F., Mori, T., DelleDonne, A., Crescentini, R., Obregon, D., Flavell, R. A., & Mullan, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn968 · Cited by 217 · cited 1×
“Although microglial activation has been shown to be a feature of neurodegenerative diseases and models of neurodegenerative diseases (O’Keefe et al. 2002; Tan et al. 2002; McGeer and McGeer 2004), the evidence indicating a similar change in the aged brain is equivocal.”
BackgroundOpazo, P., Watabe, A. M., Grant, S. G. N., & O'Dell, T. J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03679.2003 · Cited by 215 · cited 2×
“These changes mirror the decrease in hippocampal IGF-1 concentration and, although the effect of LTP on kinase activity was not assessed here, the data presented highlight a correlation between activation of PI-3 kinase and Akt and LTP, which has been reported previously (Kelly and Lynch 2000; Sanna et al. 2002; Opazo…”
BackgroundRamsey, M. M., Weiner, J. L., Moore, T. P., Carter, C. S., & Sonntag, W. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.001 · Cited by 101 · cited 1×
“It is generally accepted that the activity of the growth hormone–IGF-1 axis is reduced with age (see Mattson et al. 2004) and that IGF-1 can ameliorate age-related deficits in certain forms of learning and memory (Ramsey et al. 2004).”
BackgroundIncreased IL-1β in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase
Maher, F. O., Martin, D. S. D., & Lynch, M. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.007 · Cited by 73
Self-citation
Cited by
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders
Profenno, L. A., Porsteinsson, A. P., & Faraone, S. V. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.013 · Cited by 718
Microglial cell dysregulation in brain aging and neurodegeneration
von Bernhardi, R., Eugenín-von Bernhardi, L., & Eugenín, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00124 · Cited by 556
Varnum, M. M., & Ikezu, T. (2012) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-012-0181-2 · Cited by 394
Dilger, R. N., & Johnson, R. W. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0208108 · Cited by 391
Dyer, A. H., Vahdatpour, C., Sanfeliu, A., & Tropea, D. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.056 · Cited by 377
Neurovascular signalling defects in neurodegeneration
Zacchigna, S., Lambrechts, D., & Carmeliet, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2336 · Cited by 345
“Other angioneurins, such as IGF1, EGF and FGF2, also augment LTP through direct and indirect mechanism”
BackgroundANISMAN, H., MERALI, Z., & HAYLEY, S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.004 · Cited by 337
Anisman, H. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0902 · Cited by 292
Neuroinflammation and cognitive function in aged mice following minor surgery
Rosczyk, H. A., Sparkman, N. L., & Johnson, R. W. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.06.004 · Cited by 271
The multifaceted profile of activated microglia
Lynch, M. A. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8077-9 · Cited by 268
Self-citationKohman, R. A., DeYoung, E. K., Bhattacharya, T. K., Peterson, L. N., & Rhodes, J. S. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.10.006 · Cited by 176
Age-related neuroinflammatory changes negatively impact on neuronal function
Lynch, M. A. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.006.2009 · Cited by 174
“IFNγ IS A POTENT ACTIVATOR OF MICROGLIA IFNγ is known to be one of the most potent activators of microglia (Benveniste et al., 2004) and, predictably, its expression is increased in the brain of aged animals (Maher et al., 2006; Moore et al., 2007; Clarke et al., 2008).”
Self-citationNeuroinflammatory changes negatively impact on LTP: A focus on IL-1β
Lynch, M. A. (2015) · Brain Research · doi:10.1016/j.brainres.2014.08.040 · Cited by 115
“…path-granule cell synapses of urethane-anaesthetized rats perhaps as a consequence of microglial activation and the associated increase in IL-1β (Maher et al., 2006), while the inhibitory effect of IFNγ on LTP in CA1 in vitro was also associated with increased IL-1β and microglial activation…”
Self-citationZhong, Y., Zhou, L.-J., Ren, W.-J., Xin, W.-J., Li, Y.-Y., Zhang, T., & Liu, X.-G. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.01.007 · Cited by 97
Gutiérrez‐Martos, M., Girard, B., Mendonça‐Netto, S., Perroy, J., Valjent, E., Maldonado, R., & Martin, M. (2018) · Addiction Biology · doi:10.1111/adb.12541 · Cited by 35
Metadata
- Authors
- Maher, F. O., Clarke, R. M., Kelly, A., Nally, R. E., & Lynch, M. A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2006-02-08
- Volume
- 96
- Issue
- 6
- Pages
- 1560-1571
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1964186052
- Cited by
- 81
- References
- 9
- FWCI
- 3.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.